ONYX PHARMACEUTICALS INC — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$362.2M

Net Income/Loss (FY2012)

-$187.8M

Total Assets (FY2012)

$1.4B

Total Equity (FY2012)

$820.1M

Cash Flows from Operating Activities (FY2012)

-$230.5M

Source: ONYX PHARMACEUTICALS INC 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.